In this webinar we introduce Characterization of Bioceramics for Surgical Implants using analytical tools for full qualification.
Bioceramics are an important subset of biomaterials, employed in medical and orthopedic applications, mainly for the repair and replacement of diseased and damaged parts of the human skeleton, bone, teeth, and joints. Based on the common response of tissues to implants, bioceramics are classified into three groups: (1) bioinert ceramics, e.g., Al2O3, and ZrO2; (2) bioactive ceramics, e.g., hydroxyapatite (HAp); and (3) bioresorbable ceramics such as b- tricalcium phosphate (b-TCP). With the advent of many bioceramic compositions, it has been the primary focus of this field to ensure the safety of newly developed or currently used materials.
The safety and reliability concerns regarding bioceramics originates from the potential prolonged leaching of ions in the physiological environment, from the integrity of the tissue/implant interface, and from the fatigue fracture and wear behavior of load-bearing implants. HAp, b-TCP, and calcium sulfate hemihydrate and dihydrate have long been recognized as appropriate materials for bones, due to their chemical and biological similarity to human hard tissues. Properly screening bioceramic powders and fabricated implant parts, prior to in vitro and in vivo tests, is appealing in term of safety, and time- and cost-savings.
In this webinar, we will demonstrate how modern analytical tools (Scheme) can be used for full qualification of bioceramic precursors, including following FDA recognized consensus standards (such as ASTM F1088, F1185, F2024, F2224, ISO 13175-3, 13779-2, 13779-3, and USP 232/Q3D).
In this webinar we will cover:
To enable certain features and improve your experience with us, this site stores cookies on your computer. Please click Continue to provide your authorization and permanently remove this message.